Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;69(1):46-50.
doi: 10.1002/acr.22941. Epub 2016 Nov 16.

Risk of Malignancy Among Patients With Sarcoidosis: A Population-Based Cohort Study

Patompong Ungprasert  1 , Cynthia S Crowson  1 , Eric L Matteson  1
Affiliations

Risk of Malignancy Among Patients With Sarcoidosis: A Population-Based Cohort Study

Patompong Ungprasert et al. Arthritis Care Res (Hoboken). 2017 Jan.

Abstract

Objective: To investigate the risk of malignancy in patients with sarcoidosis in a population-based cohort.

Methods: A cohort of Olmsted County, Minnesota, residents diagnosed with sarcoidosis between January 1, 1976 and December 31, 2013 was identified based on individual medical record review. For each sarcoidosis subject, 2 sex- and age-matched comparator subjects without sarcoidosis were randomly selected. Cases and comparators were then cross-indexed with the Mayo Clinic Cancer Registry, which collected data on every type of malignancy except for nonmelanoma skin cancer, for malignancy ascertainment.

Results: A total of 345 incident cases of sarcoidosis and 690 comparators were identified. There was no difference in the prevalence of malignancy at the index date between the 2 groups (4.3% among cases and 4.3% among comparators; P = 1.0). During followup, 36 patients with sarcoidosis and 91 subjects without sarcoidosis developed malignancy, with a cumulative incidence at 10 years of 3.8% and 7.1%, respectively. The difference corresponded to a hazard ratio (HR) of 0.72 (95% confidence interval [95% CI] 0.49-1.06). The cumulative incidences at 10 years for individual types of malignancy were also similar between the 2 groups, with nonsignificant HRs. However, subgroup analysis found that cases with extrathoracic involvement were at higher risk of incident hematologic malignancy compared with cases without extrathoracic involvement (HR 1.87 [95% CI 1.09-3.22]).

Conclusion: Risk of malignancy was similar among patients with sarcoidosis compared to nonsarcoidosis subjects. However, the risk of incident hematologic malignancy was significantly higher among patients with sarcoidosis with extrathoracic involvement compared to patients without extrathoracic disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A: Cumulative incidence of any cancer excluding non-melanoma skin cancers (sarcoidosis-solid line; non-sarcoidosis dashed line). B: Cumulative incidence of hematologic cancer (sarcoidosis with extra-thoracic involvement: solid line; sarcoidosis without extra-thoracic involvement: dashed line)
See this image and copyright information in PMC

References

    1. Thomas WK, Hunninghake GW. Sarcoidosis. JAMA. 2003;289:3300–3. - PubMed
    1. Rybicki BA, Major M, Popovich J, Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–241. - PubMed
    1. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–30. - PubMed
    1. Suen JS, Forse MS, Hyland RH, Chan CK. The malignancy-sarcoidosis syndrome. Chest. 1990;96:1300–1. - PubMed
    1. Askling J, Grunewald J, Eklund A, Hillerdl G, Ekbom A. Increased risk of cancer following sarcoidosis. Am J Respir Crit Care Med. 1999;160:1668–72. - PubMed

Publication types

LinkOut - more resources